Construction method and application of African swine fever virus protein eukaryotic expression vector with immunosuppressive effect
By constructing the eukaryotic expression vector pcDNA3.1-B119L of the African swine fever virus B119L gene, the inhibition of the cellular immune response was solved, and the problem of difficult inhibition of cells' immune response to Poly(dT:dT), Poly(I:C), and exogenous IFN-β in the prior art was solved, which proved the immunosuppressive function of the B119L protein and laid the foundation for related research.
Patent Information
- Application Number
- CN202411879349.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-19
- Publication Date
- 2025-03-18
AI Technical Summary
The prior art is difficult to effectively inhibit the immune response of cells to Poly(dT:dT), Poly(I:C), and exogenous IFN-β, especially in the study of the B119L protein of African swine fever virus.
By designing specific primers and Flag tag sequences, the eukaryotic expression vector pcDNA3.1-B119L of the African swine fever virus B119L gene was constructed, and the expression of B119L protein was achieved through PCR amplification and enzyme cleavage and ligation to inhibit the immune response of cells to Poly(dT:dT), Poly(I:C), and exogenous IFN-β.
It successfully inhibited the immune response of cells to Poly(dT:dT), Poly(I:C), and exogenous IFN-β, proved the immunosuppressive function of B119L protein, and laid the foundation for the study of the biological function of B119L protein of African swine fever virus.